Advent International

Photo
16.02.2023 • News

All Signals Point to ”Go” for new Plastics Firm

With merger clearance granted by India this week, nothing now stands in the way of plans by German chemical producer Lanxess and private equity investor Advent International to create a 40:60 joint venture for high performance engineering plastics with annual sales of around €300 million.

Photo
28.10.2022 • News

Röhm and OQ break ground on Texas MMA Plant

Together with compatriot project partner OQ Chemicals, Germany’s Röhm has broken ground on a new world-scale methyl methacrylate (MMA) plant it is building at OQ Chemicals’ Bay City, Texas site.

Photo
19.09.2022 • News

Calum MacLean to Head Lanxess-Advent JV

German specialty chemicals producer Lanxess and private equity group Advent International have named Calum MacLean as CEO-designate of their planned joint venture for high-performance engineering plastics.

Photo
01.06.2022 • News

Lanxess and Advent Clinch DSM Plastics Deal

German specialty chemicals producer Lanxess and private equity investor Advent International have clinched a carefully constructed deal to buy DSM’s engineering plastics business for around €3.7 billion. The assets will then be merged with the Lanxess engineering plastics portfolio to create a new market player with annual sales of around €3 billion.

Photo
02.08.2019 • News

Evonik’s Sale of Röhm to Advent Closes

With the transfer of Evonik’s methacrylates business to private equity investor Advent International, Röhm, one of the world’s leading producers of methyl methacrylate (MMA) monomer and PMMA molding compounds, is now called Röhm again. The company based at Darmstadt, Germany, also has a new logo.

Photo
07.02.2017 • TopicsStrategy

A Visible Turning Point for Oxea

Ten years ago, in March 2007, oxo chemicals producer Oxea was established as a buyout led by private-equity firm Advent International of oxo derivatives and oxo intermediates businesses from Celanese and European Oxo.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.